Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients

Pages
2437–2444
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results of our study revealed that fQRS (+) acromegaly patients had increased LVH parameters compared to fQRS (-) patients.Key words: Acromegaly, fragmented QRS, left ventricular hypertrophy, left ventricular mass

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: It is known that the presence of fragmented QRS (fQRS) on electrocardiography (ECG) is associated with cardiovascular events.
📊
Key Findings & Data:Materials and methods: In total, 47 previously diagnosed with non-hypertensive acromegaly patients and 48 control subjects were included in the study.
💡
Conclusion & Impact:Conclusion: The results of our study revealed that fQRS (+) acromegaly patients had increased LVH parameters compared to fQRS (-) patients.Key words: Acromegaly, fragmented QRS, left ventricular hypertrophy, left ventricular mass
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: It is known that the presence of fragmented QRS (fQRS) on electrocardiography (ECG) is associated with cardiovascular events. The aim of this study was the evaluation of fQRS formation and its relationship with the left ventricular hypertrophy (LVH) parameters in acromegaly patients. Materials and methods: In total, 47 previously diagnosed with non-hypertensive acromegaly patients and 48 control subjects were included in the study. ECG and transthoracic echocardiography (TTE) were performed for each participant. Acromegaly patients were divided into two groups according to the fQRS formation on the ECG. Left ventricular wall thicknesses, and left atrial diameter (LAD), left ventricular mass (LVM), left ventricular mass index (LVMi), and relative wall thickness (RWT) were obtained. Results: In control group 5 (10.4%) and in acromegaly group 17 (36.2%) patients had fQRS on ECG (p = 0.003). LAD [36.0 (34.0–38.0) vs. 38.0 (35.0–41.0) mm, p < 0.001], LVM [155.27 ± 27.00 vs. 173.0 (153.0–235.0) g, p < 0.001], LVMi [83.12 ± 13.19 vs. 92.0 (83.0–118.0) g/m², p < 0.001] and RWT [0.39 ± 0.03 vs. 0.43 (0.41–0.45), p = 0.001] were significantly higher in patients with acromegaly. Disease duration was significantly higher (11.59 ± 1.3 vs. 8.2 ± 1.8 years, p < 0.001) in the fQRS (+) group. LAD [41.0 (39.0–42.5) vs. 37.0 (34.7– 38.0) mm, p < 0.001], LVM [219.0 (160.5–254.5) vs. 164.0 (153.0–188.0) g, p = 0.017], LVMi [117.0 (92.5–128.5) vs. 86.0 (82.0–100.2) g/m², p = 0.013] and RWT [0.44 (0.42–0.49) vs. 0.43 (0.40–0.44), p = 0.037] were significantly higher in fQSR (+) acromegaly patients. In multivariate logistic regression analysis, disease duration (odds ratio: 10.05, 95% CI: 1.099–92.012, p = 0.041) and LAD (odds ratio: 2.19, 95% CI: 1.030–4.660, p = 0.042) were found to be the independent predictors of fQRS formation. Conclusion: The results of our study revealed that fQRS (+) acromegaly patients had increased LVH parameters compared to fQRS (-) patients.Key words: Acromegaly, fragmented QRS, left ventricular hypertrophy, left ventricular mass

🔖

Cite This Article

MERT, K. U., YORULMAZ, G., MURAT, S., DURAL, M., ALAGÜNEY, E. S., YILMAZ, A. S., KEBAPÇI, N., CAMLI, E., EFE, B., AKALIN, A., KALKAN, A. T. (2022). Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2437–2444. https://ajindex.com/articles/609373

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Lopez-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM et al. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? The Journal of Clinical Endocrinology & Metabolism 1997
  2. 82 (4): 1047-1053. doi:10.1210/jcem.82.4.3876 2. Dural M, Kabakci G, Cinar N, Erbas T, Canpolat U et al. Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly. Pituitary 2012
  3. 17 (2): 163-170. doi: 10.1007/s11102-013-0482-4 3. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004
  4. 25 (1): 102-152. doi:10.1210/er.2002-0022 4. Lopes MB. Growth hormone-secreting adenomas: pathology and cell biology. Neurosurgical Focus 2010
  5. 29 (4): E2. doi:10.3171/2010.7.FOCUS10169 5. Colao A, Pivonello R, Grasso LF, Auriemma RS, Galdiero M et al. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. European Journal of Endocrinology 2011
  6. 165 (5): 713-721. doi: 10.1530/ EJE-11-0408 6. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. New England Journal of Medicine 1999
  7. 341 (17): 1276-1283. doi: 10.1056/NEJM199910213411706 7. Wahlander H, Isgaard J, Jennische E, Friberg P. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension 1992 19 (1): 25-32. doi: 10.1161/01.hyp.19.1.25 8. Fu ML, Tornell J, Schulze W, Hoebeke J, Isaksson OG et al. Myocardial hypertrophy in transgenic mice overexpressing the bovine growth hormone (bGH) gene. Journal of Internal Medicine 2999
  8. 247 (5): 546-552. doi:10.1046/j.1365- 2796.2000.00651.x 9. Goldberg MD, Vadera N, Yandrapalli S, Frishman WH. Acromegalic cardiomyopathy: an overview of risk factors. Clinical Manifestations, and Therapeutic Options. Cardiology in Review 2018
  9. 26 (6): 307-311. doi: 10.1097/ CRD.0000000000000215 10. Guo X, Gao L, Zhang S, Li Y, Wu Y et al. Cardiovascular system changes and related risk factors in acromegaly patients: a casecontrol study. International Journal of Endocrinology 2015: 573643. doi:10.1155/2015/573643 11. Akdeniz B, Gedik A, Turan O, Ozpelit E, Ikiz AO et al. Evaluation of left ventricular diastolic function according to new criteria and determinants in acromegaly. International Heart Journal 2012
  10. 53 (5): 299-305. doi:10.1536/ihj.53.299 12. Jurcut R, Galoiu S, Florian